The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bullen, D. V. R.
Right arrow Articles by Handman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bullen, D. V. R.
Right arrow Articles by Handman, E.
The Journal of Immunology, 2003, 170: 4267-4272.
Copyright © 2003 by The American Association of Immunologists

Persistence of Lesions in Suppressor of Cytokine Signaling-1-Deficient Mice Infected with Leishmania major1

Denise V. R. Bullen, Tracey M. Baldwin, Joan M. Curtis, Warren S. Alexander and Emanuela Handman2

The Walter & Eliza Hall Institute of Medical Research and the Cooperative Research Center for Cellular Growth Factors, Royal Melbourne Hospital, Victoria, Australia

To investigate the role of the cytokine IFN-{gamma} and its negative regulator, the suppressor of cytokine signaling-1 (SOCS1) in the progression of cutaneous leishmaniasis, we infected mice lacking a single copy of the gene encoding SOCS1 (SOCS1+/-), mice lacking both copies of IFN-{gamma} (IFN-{gamma}-/-), or mice lacking copies of both SOCS1 and IFN-{gamma} (SOCS1-/- IFN-{gamma}-/-), with a moderate dose of 103 or 104 of the most virulent stage of parasites, metacyclic promastigotes. Surprisingly, SOCS1+/- mice developed larger lesions than wild-type mice, although the parasite load in the draining lymph node was not significantly altered. These mice also developed apparently normal Th1 responses, as indicated by elevated levels of IFN-{gamma} and low levels of IL-4 and IL-10. The persistence of lesions and the enlargement of draining lymph nodes despite a normal Th1 response and control of parasitemia indicate that there may be a dissociation of the inflammatory pathology and clearance of parasites in SOCS1+/- mice. We also investigated the role of the related suppressor of cytokine signaling, SOCS2, which has been implicated in the development of Th1 immunity. The progression of disease in SOCS2-/- mice did not differ from that in C57BL/6 control mice, suggesting that it is not involved in the host response to Leishmania major infection and supporting the specific role of SOCS1. These results suggest that SOCS1 plays an important role in the regulation of appropriate inflammatory responses during the resolution of L. major infection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Yang, P. Stark, K. Janik, H. Wigzell, and M. E. Rottenberg
SOCS-1 Protects against Chlamydia pneumoniae-Induced Lethal Inflammation but Hampers Effective Bacterial Clearance
J. Immunol., March 15, 2008; 180(6): 4040 - 4049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Zimmermann, P. J. Murray, K. Heeg, and A. H. Dalpke
Induction of Suppressor of Cytokine Signaling-1 by Toxoplasma gondii Contributes to Immune Evasion in Macrophages by Blocking IFN-{gamma} Signaling
J. Immunol., February 1, 2006; 176(3): 1840 - 1847.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Brender, R. Columbus, D. Metcalf, E. Handman, R. Starr, N. Huntington, D. Tarlinton, N. Odum, S. E. Nicholson, N. A. Nicola, et al.
SOCS5 Is Expressed in Primary B and T Lymphoid Cells but Is Dispensable for Lymphocyte Production and Function
Mol. Cell. Biol., July 1, 2004; 24(13): 6094 - 6103.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.